HER1 Gene

The HER1 Gene, also widely known as the Epidermal Growth Factor Receptor (EGFR) gene, plays a pivotal role in regulating cell growth, division, and survival. Its proper function is essential for normal physiological processes, but its dysregulation is frequently implicated in the development and progression of various cancers.

HER1 Gene

Key Takeaways

  • The HER1 Gene is synonymous with the Epidermal Growth Factor Receptor (EGFR) gene.
  • It encodes a cell surface receptor crucial for cell proliferation, differentiation, and survival.
  • Dysregulation, often through mutations or overexpression, can lead to uncontrolled cell growth characteristic of cancer.
  • The HER1 Gene is a significant target for various cancer therapies due to its role in oncogenesis.

What is the HER1 Gene (EGFR)?

The HER1 Gene, also known as the Epidermal Growth Factor Receptor (EGFR) gene, is a protein-coding gene located on chromosome 7 in humans. It is a member of the ErbB family of receptor tyrosine kinases. The protein encoded by this gene, EGFR, is a cell surface receptor that binds to various extracellular ligands, most notably epidermal growth factor (EGF).

When EGF or other ligands bind to EGFR, it triggers a cascade of intracellular signaling pathways. This activation is fundamental for transmitting external signals into the cell, influencing critical cellular processes. Understanding what is HER1 Gene involves recognizing its dual identity as both a normal cellular regulator and a potential oncogene when its activity becomes uncontrolled.

HER1 Gene Function and Cellular Role

The primary HER1 gene function is to act as a receptor for growth factors, initiating intracellular signaling pathways that control fundamental cellular activities. Upon ligand binding, EGFR undergoes dimerization and autophosphorylation, activating downstream signaling cascades such as the RAS/MAPK, PI3K/AKT, and STAT pathways. These pathways regulate a wide array of cellular processes, including:

  • Cell Proliferation: Stimulating cell division and growth.
  • Cell Differentiation: Guiding cells to specialize into different types.
  • Cell Survival: Preventing programmed cell death (apoptosis).
  • Cell Migration and Adhesion: Facilitating cell movement and attachment.
  • Angiogenesis: Promoting the formation of new blood vessels.

These roles highlight the HER1 Gene’s critical importance in normal physiological processes, including embryonic development, tissue repair, and maintaining tissue homeostasis. Its precise regulation ensures controlled cellular responses to external cues, vital for the health and integrity of an organism.

HER1 Gene’s Role in Cancer Development

Dysregulation of the HER1 Gene is a well-established driver in the development and progression of various cancers, often referred to as HER1 gene cancer. This dysregulation can occur through several mechanisms, including gene amplification, overexpression of the EGFR protein, or activating mutations within the gene itself. For instance, activating mutations in the EGFR gene are found in approximately 10-15% of non-small cell lung cancers (NSCLC) in Western populations and up to 50% in East Asian populations, as reported by the American Cancer Society.

When the HER1 Gene is overactive or mutated, it leads to constitutive activation of the downstream signaling pathways, even in the absence of ligand binding. This uncontrolled signaling promotes hallmark features of cancer, such as:

  • Unrestricted cell proliferation.
  • Enhanced cell survival and resistance to apoptosis.
  • Increased angiogenesis, providing nutrients to tumors.
  • Metastasis, facilitating the spread of cancer cells to distant sites.

The HER1 Gene’s prominent role in oncogenesis has made it a significant target for molecularly targeted therapies, such as tyrosine kinase inhibitors (TKIs), which aim to block its aberrant activity and inhibit tumor growth in patients with EGFR-driven cancers.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.